Literature DB >> 26311769

Bexarotene-Activated Retinoid X Receptors Regulate Neuronal Differentiation and Dendritic Complexity.

Anais Mounier1, Danko Georgiev1, Kyong Nyon Nam1, Nicholas F Fitz1, Emilie L Castranio1, Cody M Wolfe1, Andrea A Cronican1, Jonathan Schug2, Iliya Lefterov3, Radosveta Koldamova3.   

Abstract

Bexarotene-activated retinoid X receptors (RXRs) ameliorate memory deficits in Alzheimer's disease mouse models, including mice expressing human apolipoprotein E (APOE) isoforms. The goal of this study was to gain further insight into molecular mechanisms whereby ligand-activated RXR can affect or restore cognitive functions. We used an unbiased approach to discover genome-wide changes in RXR cistrome (ChIP-Seq) and gene expression profile (RNA-Seq) in response to bexarotene in the cortex of APOE4 mice. Functional categories enriched in both datasets revealed that bexarotene-liganded RXR affected signaling pathways associated with neurogenesis and neuron projection development. To further validate the significance of RXR for these functions, we used mouse embryonic stem (ES) cells, primary neurons, and APOE3 and APOE4 mice treated with bexarotene. In vitro data from ES cells confirmed that bexarotene-activated RXR affected neuronal development at different levels, including proliferation of neural progenitors and neuronal differentiation, and stimulated neurite outgrowth. This effect was validated in vivo by demonstrating an increased number of neuronal progenitors after bexarotene treatment in the dentate gyrus of APOE3 and APOE4 mice. In primary neurons, bexarotene enhanced the dendritic complexity characterized by increased branching, intersections, and bifurcations. This effect was confirmed by in vivo studies demonstrating that bexarotene significantly improved the compromised dendritic structure in the hippocampus of APOE4 mice. We conclude that bexarotene-activated RXRs promote genetic programs involved in the neurogenesis and development of neuronal projections and these results have significance for the improvement of cognitive deficits. SIGNIFICANCE STATEMENT: Bexarotene-activated retinoid X receptors (RXRs) ameliorate memory deficits in Alzheimer's disease mouse models, including mice expressing human apolipoprotein E (APOE) isoforms. The goal of this study was to gain further insight into molecular mechanisms whereby ligand-activated RXR can affect or restore cognitive functions. We used an unbiased approach to discover genome-wide changes in RXR cistrome (ChIP-Seq) and gene expression profile (RNA-Seq) in response to bexarotene in the cortex of APOE4 mice. Functional categories enriched in both datasets revealed that liganded RXR affected signaling pathways associated with neurogenesis and neuron projection development. The significance of RXR for these functions was validated in mouse embryonic stem cells, primary neurons, and APOE3 and APOE4 mice treated with bexarotene.
Copyright © 2015 the authors 0270-6474/15/3511862-15$15.00/0.

Entities:  

Keywords:  APOE4 and APOE3; ChIP-Seq/RNA-Seq; adult neurogenesis; bexarotene; neuronal differentiation; retinoid X receptor

Mesh:

Substances:

Year:  2015        PMID: 26311769      PMCID: PMC4549399          DOI: 10.1523/JNEUROSCI.1001-15.2015

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  82 in total

1.  Acute treatment with the PPARgamma agonist pioglitazone and ibuprofen reduces glial inflammation and Abeta1-42 levels in APPV717I transgenic mice.

Authors:  Michael T Heneka; Magdalena Sastre; Lucia Dumitrescu-Ozimek; Anne Hanke; Ilse Dewachter; Cuno Kuiperi; Kerry O'Banion; Thomas Klockgether; Fred Van Leuven; Gary E Landreth
Journal:  Brain       Date:  2005-04-07       Impact factor: 13.501

2.  Light and electron microscopic immunohistochemical detection of bromodeoxyuridine-labeled cells in the brain: different fixation and processing protocols.

Authors:  Laura B Ngwenya; Alan Peters; Douglas L Rosene
Journal:  J Histochem Cytochem       Date:  2005-07       Impact factor: 2.479

3.  The TREES toolbox--probing the basis of axonal and dendritic branching.

Authors:  Hermann Cuntz; Friedrich Forstner; Alexander Borst; Michael Häusser
Journal:  Neuroinformatics       Date:  2011-03

4.  Increasing adult hippocampal neurogenesis is sufficient to improve pattern separation.

Authors:  Amar Sahay; Kimberly N Scobie; Alexis S Hill; Colin M O'Carroll; Mazen A Kheirbek; Nesha S Burghardt; André A Fenton; Alex Dranovsky; René Hen
Journal:  Nature       Date:  2011-04-03       Impact factor: 49.962

5.  Comment on "ApoE-directed therapeutics rapidly clear β-amyloid and reverse deficits in AD mouse models".

Authors:  Ina Tesseur; Adrian C Lo; Anouk Roberfroid; Sofie Dietvorst; Bianca Van Broeck; Marianne Borgers; Harrie Gijsen; Diederik Moechars; Marc Mercken; John Kemp; Rudi D'Hooge; Bart De Strooper
Journal:  Science       Date:  2013-05-24       Impact factor: 47.728

6.  Comment on "ApoE-directed therapeutics rapidly clear β-amyloid and reverse deficits in AD mouse models".

Authors:  Karthikeyan Veeraraghavalu; Can Zhang; Sean Miller; Jasmin K Hefendehl; Tharinda W Rajapaksha; Jason Ulrich; Mathias Jucker; David M Holtzman; Rudolph E Tanzi; Robert Vassar; Sangram S Sisodia
Journal:  Science       Date:  2013-05-24       Impact factor: 47.728

7.  Characterization of three RXR genes that mediate the action of 9-cis retinoic acid.

Authors:  D J Mangelsdorf; U Borgmeyer; R A Heyman; J Y Zhou; E S Ong; A E Oro; A Kakizuka; R M Evans
Journal:  Genes Dev       Date:  1992-03       Impact factor: 11.361

8.  The liver X receptor ligand T0901317 decreases amyloid beta production in vitro and in a mouse model of Alzheimer's disease.

Authors:  Radosveta P Koldamova; Iliya M Lefterov; Matthias Staufenbiel; Darren Wolfe; Shaohua Huang; Joseph C Glorioso; Michael Walter; Michael G Roth; John S Lazo
Journal:  J Biol Chem       Date:  2004-11-22       Impact factor: 5.157

9.  LXRs control lipid-inducible expression of the apolipoprotein E gene in macrophages and adipocytes.

Authors:  B A Laffitte; J J Repa; S B Joseph; D C Wilpitz; H R Kast; D J Mangelsdorf; P Tontonoz
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-09       Impact factor: 11.205

10.  Class 3 semaphorin mediates dendrite growth in adult newborn neurons through Cdk5/FAK pathway.

Authors:  Teclise Ng; Jae Ryun Ryu; Jae Ho Sohn; Terence Tan; Hongjun Song; Guo-Li Ming; Eyleen L K Goh
Journal:  PLoS One       Date:  2013-06-10       Impact factor: 3.240

View more
  25 in total

1.  Lipidated APOE has effects on cognitive function that are independent of amyloid-β pathology.

Authors:  Angela Corona; Gary Landreth
Journal:  Brain       Date:  2015-12       Impact factor: 13.501

Review 2.  Therapeutic potential of nuclear receptor agonists in Alzheimer's disease.

Authors:  Miguel Moutinho; Gary E Landreth
Journal:  J Lipid Res       Date:  2017-03-06       Impact factor: 5.922

3.  Apolipoprotein E*4 (APOE*4) Genotype Is Associated with Altered Levels of Glutamate Signaling Proteins and Synaptic Coexpression Networks in the Prefrontal Cortex in Mild to Moderate Alzheimer Disease.

Authors:  Robert A Sweet; Matthew L MacDonald; Caitlin M Kirkwood; Ying Ding; Tadhg Schempf; Jackie Jones-Laughner; Julia Kofler; Milos D Ikonomovic; Oscar L Lopez; Megan E Garver; Nicholas F Fitz; Radosveta Koldamova; Nathan A Yates
Journal:  Mol Cell Proteomics       Date:  2016-04-21       Impact factor: 5.911

Review 4.  Nuclear receptors in neural stem/progenitor cell homeostasis.

Authors:  Dimitrios Gkikas; Matina Tsampoula; Panagiotis K Politis
Journal:  Cell Mol Life Sci       Date:  2017-06-21       Impact factor: 9.261

Review 5.  Therapeutic targeting of nuclear receptors, liver X and retinoid X receptors, for Alzheimer's disease.

Authors:  Nicholas F Fitz; Kyong Nyon Nam; Radosveta Koldamova; Iliya Lefterov
Journal:  Br J Pharmacol       Date:  2019-05-11       Impact factor: 8.739

6.  High-mobility group nucleosomal binding domain 2 protects against microcephaly by maintaining global chromatin accessibility during corticogenesis.

Authors:  Xue-Ling Gao; Wen-Jia Tian; Bofeng Liu; Jingyi Wu; Wei Xie; Qin Shen
Journal:  J Biol Chem       Date:  2019-11-07       Impact factor: 5.157

Review 7.  Peripheral versus central nervous system APOE in Alzheimer's disease: Interplay across the blood-brain barrier.

Authors:  Dustin Chernick; Stephanie Ortiz-Valle; Angela Jeong; Wenhui Qu; Ling Li
Journal:  Neurosci Lett       Date:  2019-06-07       Impact factor: 3.046

Review 8.  LXR Regulation of Brain Cholesterol: From Development to Disease.

Authors:  Rebecca Courtney; Gary E Landreth
Journal:  Trends Endocrinol Metab       Date:  2016-04-21       Impact factor: 12.015

9.  Neuroprotective effect of naturally occurring RXR agonists isolated from Sophora tonkinensis Gagnep. on amyloid-β-induced cytotoxicity in PC12 cells.

Authors:  Wei Wang; Ken-Ichi Nakashima; Takao Hirai; Makoto Inoue
Journal:  J Nat Med       Date:  2018-10-30       Impact factor: 2.343

10.  Bexarotene Binds to the Amyloid Precursor Protein Transmembrane Domain, Alters Its α-Helical Conformation, and Inhibits γ-Secretase Nonselectively in Liposomes.

Authors:  Frits Kamp; Holger A Scheidt; Edith Winkler; Gabriele Basset; Hannes Heinel; James M Hutchison; Loren M LaPointe; Charles R Sanders; Harald Steiner; Daniel Huster
Journal:  ACS Chem Neurosci       Date:  2018-05-11       Impact factor: 4.418

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.